Economic burden of seasonal influenza in the United States

Vaccine

Volumn 36, Issue 27, 2018, Pages 3960-3966

  Putri, Wayan C W S ^a,b   Muscatello, David J ^a   Stockwell, Melissa S ^c   Newall, Anthony T ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UDAYANA UNIVERSITY   (Indonesia)

^c Columbia University ^*  (United States)

Author keywords

Cost of illness; Disease burden; Economic burden; Influenza; Productivity

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COST OF ILLNESS; DISEASE BURDEN; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MORTALITY RATE; OUTPATIENT; PRODUCTIVITY; SEASONAL INFLUENZA; SOCIETY; UNITED STATES; ABSENTEEISM; AMBULATORY CARE; ECONOMICS; HEALTH CARE DELIVERY; INFLUENZA; MIDDLE AGED; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; VACCINATION;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; MIDDLE AGED; SEASONS; UNITED STATES; VACCINATION;

EID: 85047238367     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2018.05.057     Document Type: Article

References (48)

1. Monto, A.S., Epidemiology of influenza. Vaccine, 26, 2008, D45.
2. Influenza virus infections in humans. World Health Organization; 2014.
3. Grohskopf L, Sokolow L, Broder K, Olsen S, Karron R, Jernigan D, et al. Prevention and control of seasonal influenza with vaccines recommendations of the advisory committee on immunization practices — United States, 2016–17 influenza season. Mortality and Morbidity Weekly Report (MMWR) 65, 2016, 1–52.
4. Wong, K.K., Cheng, P., Foppa, I., Jain, S., Fry, A.M., Finelli, L., Estimated paediatric mortality associated with influenza virus infections, United States, 2003–2010. Epidemiol Infect. 143 (2015), 640–647.
5. Molinari, N.-A.M., Ortega-Sanchez, I.R., Messonnier, M.L., Thompson, W.W., Wortley, P.M., Weintraub, E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25 (2007), 5086–5096.
6. Flu Vaccination Coverage, United States, 2015-16 Influenza Season. Centre for Disease Control and Prevention; 2016. Available from: www.cdc.gov/flu/fluvaxview/coverage-1516estimates.htm.
7. Zilberberg, M.D., Shorr, A.F., Understanding cost-effectiveness. Clin Microbiol Infect 16 (2010), 1707–1712.
8. Zierler, B.K., Gray, D.T., The principles of cost-effectiveness analysis and their application. J Vasc Surg 37 (2003), 226–234.
9. Drummond, M., Methods for the economic evaluation of health care programmes. fourth ed., 2015, Oxford University Press.
10. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2010 to July 1, 2015; 2015 [cited 2016 1 August]. Available from: http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk.
11. Tokars, J.I., Olsen, S.J., Reed, C., The seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis 66 (2018), 1511–1518.
12. Fowlkes, A., Steffens, A., Temte, J., Lonardo, S.D., McHugh, L., Martin, K., et al. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009–13. LancetRespir Med 3 (2015), 709–718.
13. Bourgeois, F.T., Valim, C., McAdam, A.J., Mandl, K.D., Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics 124 (2009), e1072–e1080.
14. Zhou, H., Thompson, W.W., Viboud, C.G., Ringholz, C.M., Cheng, P.-Y., Steiner, C., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 54 (2012), 1427–1436.
15. Quandelacy, T., Viboud, C., Charu, V., Lipsitch, M., Goldstein, E., Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997–2007. Am J Epidemiol 179 (2014), 156–167.
16. Young-Xu, Y., van Aalst, R., Russo, E., Lee, J.K., Chit, A., The annual burden of seasonal influenza in the US Veterans Affairs population. PLoS ONE, 12, 2017.
17. Simonsen, L., The global impact of influenza on morbidity and mortality. Vaccine 17:Supplement 1 (1999), S3–S10.
18. Wong, C., Yang, L., Chan, K., Leung, G., Chan, K., Guan, Y., et al. Influenza-associated hospitalization in a subtropical city. PLoS Med 3 (2006), 485–492.
19. Thompson, W., Shay, D., Weintraub, E., Brammer, L., Influenza-Associated Hospitalizations in the United States. JAMA 292 (2004), 1333–1340.
20. Carias, C., Reed, C., Kim, I.K., Foppa, I.M., Biggerstaff, M., Meltzer, M.I., et al. Net costs due to seasonal influenza vaccination-United States, 2005–2009. PLoS ONE, 10, 2015.
21. HCUPnet. Healthcare Cost and Utilization Project (HCUP): 2014 National estimates on hospital use for all patients from the HCUP National Inpatient Sample (NIS). Agency for Healthcare Research and Quality [cited 2017 2 November]. Available from: http://hcupnet.ahrq.gov.
22. Ortega-Sanchez, I.R., Molinari, N.A.M., Fairbrother, G., Szilagyi, P.G., Edwards, K.M., Griffin, M.R., et al. Indirect, out-of-pocket and medical costs from influenza-related illness in young children. Vaccine 30 (2012), 4175–4181.
23. Petrie, J.G., Cheng, C., Malosh, R.E., VanWormer, J.J., Flannery, B., Zimmerman, R.K., et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US influenza vaccine effectiveness network 2012–2013. Clin Infect Dis 62 (2015), 448–455.
24. Meltzer, M.I., Cox, N.J., Fukuda, K., The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 5 (1999), 659–671.
25. Civilian labor force participation rate by age, gender, race, and ethnicity. United States Bureau of Labor Statistics; 2015.
26. Consumer Price Index 2015: U.S. Bureau of Labor Statistics 2015 [cited 2016 1 August]. Available from: http://www.bls.gov/cpi/data.htm.
27. Buck, P.O., Smith, D.M., Shenolikar, R., Irwin, D.E., A retrospective cohort study of the incidence, healthcare resource utilization, and costs of ICD-9 diagnosed influenza and related complications in US children. Pediatr Infect Dis J. 36 (2017), 1129–1240.
28. Karve, S., Misurski, D.A., Meier, G., Davis, K.L., Employer-incurred health care costs and productivity losses associated with influenza. Hum Vaccines Immunother. 9 (2013), 841–857.
29. Physician Fee Schedule Search. Centre for Medicare & Medicaid Services; 2015.
30. Fact sheet CPT code 99213 office or other outpatient visit. Centre for Medicare and Medicaid Service; 2013.
31. Spagnuolo, P.J., Zhang, M., Xu, Y., Han, J., Liu, S., Liu, J., et al. Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006–2010. Curr Med Res Opin 32 (2016), 1399–1407.
32. Red, B.O.O.K., A comprehensive, consistent drug pricing resource. 2016, Truven Health Analytic.
33. Talbird, S.E., Brogan, A.J., Winiarski, A.P., Sander, B., Cost-effectiveness of treating influenza like illness with oseltamivir in the United States. Am J Health-Syst Pharm 66 (2009), 469–480.
34. Establishment Data Summary table B. Establishment data, seasonally adjusted. U.S. Bureau of Labor Statistics; 2015.
35. Neumann, P.J., Sanders, G.D., Russell, L.B., Siegel, J.E., Ganiats, T.G., Cost-effectiveness in health and medicine. 2016, Oxford University Press.
36. Grosse, S., Krueger, K., Mvundura, M., Economic productivity by age and sex: 2007 estimates for the United States. Med Care 47 (2009), S94–S104.
37. Employment Cost Index: U.S. Bureau of Labor Statistics [cited 2017 13 November]. Available from: https://www.bls.gov/ect/.
38. de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine in the United States. Value Health 2016.
39. Krol, M., Brouwer, W., Rutten, F., Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 31 (2013), 537–549.
40. National Health Expenditure Data. Centre for Medicare and Medicaid Service; 2016.
41. Neuzil, K., Zhu, Y., Griffin, M., Edwards, K., Thompson, J., Tollefson, S.J., et al. Burden of interpandemic influenza in children younger than 5 years: A 25-year prospective study. J Infect Dis 185 (2002), 147–152.
42. Introduction to the HCUP National Inpatient Sample (NIS) 2014. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP); 2016.
43. Smith, K.A., Rudmik, L., Cost collection and analysis for health economic evaluation. Otolaryngol–Head Neck Surg 149 (2013), 192–199.
44. Viscusi, W.K., Aldy, J.E., The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertainty 27 (2003), 5–76.
45. Matias, G., Haguinet, F., Lustig, R.L., Edelman, L., Chowell, G., Taylor, R.J., Model estimates of the burden of outpatient visits attributable to influenza in the United States. BMC Infect Dis, 16, 2016, 641.
46. Newall, A., Viboud, C., Wood, J., Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches. Epidemiol Infect 138 (2010), 836–842.
47. Izurieta, H.S., Thadani, N., Shay, D.K., Lu, Y., Maurer, A., Foppa, I.M., et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 15 (2015), 293–300.
48. Gravenstein, S., Davidson, H.E., Taljaard, M., Ogarek, J., Gozalo, P., Han, L., et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 5 (2017), 738–746.